We are inaugurating these meetings with the exceptional participation of pioneering investigators of the brain tumor heterogeneity and evolution.
Single-cell RNA sequencing technologies are one of the most recent scientific and medical breakthrough. By allowing to determine the genetic profile of individual cells from an heterogenous tumor biopsy, this technology allowed very significant progress in the understanding of the brain tumor biology and personalized diagnosis.
We are honoured to host Prof. Mario Suvà (Massachusetts General Hospital, Broad Institute of Harvard and MIT, USA) for a keynote lecture on his groudbreaking discovery recently published in Cell (https://doi.org/10.1016/j.cell.2019.06.024), revealing that glioblastoma tumour cells exhibit different phenotypic states with consequences on the tumor plasticity and progression. He will also share with us ongoing investigations on other types of brain cancers, including paediatric brain tumours and medulloblastoma.
Dr. Toshiro Hori is a main contributor in the discovery of the phenotypic states that brain tumor cells exhibit. He will comment on the story leading to this discovery and the perspectives offered by the single cell transcriptomics technology in addition to presenting us very recent data on the glioblastoma-immune cell interactions at the single-cell resolution.
Mrs. Kaiyang Zhang will share with us her experience with the computational analysis of large datasets of patient tumor cells. During this live interactive session, we will perform the analysis, on screen, while commenting on the methodology.
Save the date! We are looking forward to seeing you on October 28th.
The event is free-of-charge for FiBTRA members.
More information and registration: https://fibtra.org
Follow us on Twitter @FIBTRA_SAKTY for daily updates and interaction with the whole FiBTRA community!